Related by context. All words. (Click for frequent words.) 68 Frova ® 67 THALOMID 66 Nabi HB Intravenous 65 Biologic License Application BLA 65 COLAZAL R 65 liver resection surgeries 65 Combunox 64 Vitrasert R 64 FACTIVE R gemifloxacin 64 PROVIGIL 64 Onco TCS 64 Submits Response 64 Biological License Application 64 HYVISC R 64 SYCREST 64 Frova R 63 Civacir 63 Zenvia ™ 63 PLAVIX ® 63 IV acetaminophen 63 Somatuline Depot 63 Submits Biologics License Application 63 Receives Approvable Letter 63 Announces Tentative Approval 63 Nasdaq NPSP announced 63 Glucophage XR 63 SPARLON 63 AstraZeneca Symbicort 63 Restanza TM 63 Targretin capsules 63 RANK Ligand inhibitor 63 CIP TRAMADOL ER 63 R sorafenib tablets 63 MOVIPREP R 63 Increlex TM 63 oxymorphone ER 63 Velcade bortezomib 63 5 HT3 antagonist 63 sublingual tablets 63 Omigard 63 Barr ANDA 63 IV APAP 63 OsmoPrep 62 Initiates Enrollment 62 miconazole MBT 62 PrevOnco 62 topical NSAID 62 Lidoderm R 62 Dificid 62 Actimmune R 62 please visit www.middlebrookpharma.com 62 enoxaparin sodium injection 62 highly purified pasteurized 62 IV Busulfex 62 Nivestim 62 markets HP Acthar 62 rasagiline tablets 62 REMICADE infliximab 62 ALGRX 62 T Pred 62 VALSTAR 62 sumatriptan succinate 62 Aloxi ® 62 OLEPTRO 62 Xcytrin R 62 RAPTIVA 62 sNDAs 62 nasal calcitonin product 62 intravenous acetaminophen 62 Submits Supplemental 62 vapreotide acetate 62 docetaxel Taxotere R 62 cinacalcet HCl 62 OMP designation 62 supplemental Biologics License Application 62 granted Ortec 62 docetaxel Taxotere ® 62 Resubmission 61 Files Investigational 61 Synerx 61 Certican 61 Initiates Phase III 61 SinuNase ™ 61 casopitant 61 Orapred ODT 61 Proquin XR 61 OPANA ER 61 Lamictal ODT 61 Fanapt ® 61 BRILINTA 61 BioGlue ® 61 Marketing Authorisation Application 61 Submits NDA 61 Raptiva R 61 HepaGam B TM 61 Neulasta R 61 adalimumab Humira 61 TYGACIL 61 ARCOXIA 61 Milestone Payment 61 Psoriasis Drug 61 vinorelbine emulsion 61 Ixempra 61 Completes Patient Enrollment 61 Pegloticase 61 VIVITROL ® 61 TRISENOX ® 61 VISICOL R 61 Xyfid 61 topical ophthalmic 61 BioGlue R 61 ZEGERID Capsules 61 Temodar ® 61 Fast Track Status 61 k Premarket Notification 61 Receives Orphan Drug Designation 61 phase III isavuconazole 61 lucinactant 61 Velac 61 Mylan Receives Approval 61 ARIXTRA R 61 balsalazide tablet 61 5 lipoxygenase inhibitor 61 Expanded Indication 61 Cintredekin besudotox 61 Risperidone Oral Solution 61 Exalgo 61 Simulect 61 nonsedating antihistamine 61 PDUFA Date 61 NUEDEXTA ™ 61 Act PDUFA date 61 LUMIGAN R 61 eprodisate KIACTA TM 61 Emezine 61 Initiates Clinical Trial 61 Eloxatin ® 60 JOULFERON 60 PROTONIX 60 TAXUS Element Stent System 60 MAA submission 60 TEMODAL 60 Initiate Clinical Trial 60 Auxilium Pharma 60 Firazyr 60 Entereg alvimopan 60 thalidomide Thalomid 60 mesylate tablets approved 60 Tiuxetan 60 Mepact 60 Teflaro 60 Xolegel 60 Dacogen injection 60 Humira adalimumab 60 BEMA Granisetron 60 Sanctura XR 60 Rapaflo 60 Wellbutrin XL R 60 Saforis 60 visit www.noven.com 60 Keppra ® levetiracetam 60 Receives Tentative FDA 60 OMNARIS Nasal Spray 60 Angiox ® 60 RYZOLT 60 IONSYS TM 60 ONCASPAR 60 Fibrillex TM 60 Oracea ® 60 Zenpep 60 PRN FDA Approves 60 AMEVIVE 60 application sNDA 60 Vitrasert ® 60 dextromethorphan quinidine 60 sNDA submission 60 IL# PE#QQR 60 Zyflo CR 60 Orathecin 60 granulated mesalamine 60 ENLIGHT 60 Velaglucerase Alfa 60 PREOS R 60 Orphan Drug designations 60 Troxatyl 60 Shigamabs ® 60 POSIDUR TM 60 Evoltra R 60 Zirgan 60 hoFH 60 RECOTHROM R 60 refractory APL 60 SinuNase TM 60 Rhucin R 60 AMRIX 60 Initiates Clinical 60 Metozolv ODT 60 Feraheme ® 60 Arzerra ofatumumab 60 Romiplostim 60 Silenor ® doxepin 60 UCB Keppra 60 ferumoxytol Injection 60 Oracea R 60 balsalazide disodium Capsules 60 methylnaltrexone bromide 60 interferon gamma 1b 60 DepoDur TM 60 Liprotamase 60 POSIDUR TM ELADUR TM 60 Preotact 60 Evoltra 60 Zegerid OTC 60 telaprevir VX 60 RAPTIVA R 60 Thalidomide Pharmion 60 Fast Track designations 60 Diastat 59 Acetavance TM 59 PDUFA Prescription Drug 59 Cellegesic 59 Entocort 59 Divalproex Sodium 59 ZARS Pharma 59 faropenem medoxomil 59 REMOXY R 59 CINTREDEKIN BESUDOTOX 59 NYSE Amex PTN 59 PRIALT 59 ESTRASORB R 59 Troxatyl TM 59 Gelclair 59 Somatuline R Autogel R 59 XYREM 59 GATTEX TM 59 Premarket Approval Application 59 Biaxin XL 59 Soriatane 59 Receives Fast Track 59 Sanvar R 59 lexidronam injection 59 etanercept Enbrel 59 Zemiva TM 59 trastuzumab DM1 T DM1 59 % uracil topical 59 Zemplar 59 SPRYCEL ® 59 Drug Submission 59 Shire BioChem Inc. 59 Pexeva 59 CAELYX 59 FOLOTYN ® 59 Application BLA 59 ARCALYST ® 59 Iluvien ® 59 Actimmune ® 59 Levoleucovorin 59 Noxafil 59 Betaseron ® 59 OROS R Hydromorphone 59 OTC ZEGERID 59 mesylate tablets 59 Fortovase 59 Voraxaze 59 SUPPRELIN LA 59 visit smith.com 59 Orencia abatacept 59 Jevtana 59 Urocidin TM 59 Launches Generic Version 59 SPRIX ® 59 PENTASA 59 Peginterferon alfa 2b 59 Argatroban 59 Gamunex C 59 oral ridaforolimus 59 Soliris TM eculizumab 59 injectable formulations 59 NeutroSpec 59 TRISENOX 59 Zingo TM 59 Allegra ® 59 NDA Submission 59 MERREM IV 59 Kyowa Kirin 59 Marketing Authorisation Application MAA 59 Sirion Therapeutics 59 CONBRIZA 59 Kepivance 59 Receives Positive Opinion 59 zolpidem tartrate sublingual tablet 59 TRISENOX R 59 Hycamtin ® 59 sBLA 59 LIALDA 59 Receives Tentative Approval 59 Initiates Phase II 59 indiplon capsules 59 Demonstrates Significant 59 Octreolin 59 TORISEL 59 BioSante Pharmaceuticals Announces 59 Sunesis Pharma 59 panitumumab Vectibix 59 ILUVIEN ® 59 Friedreich Ataxia FRDA 59 RIGScan CR 59 Methylphenidate Transdermal System 59 Files IND 59 Milestone Payments 59 Fortigel 59 CancerVax Corporation 59 XIBROM 59 memantine HCl 59 vinflunine 59 Fludara ® 59 MyVax R 59 Biologic License Application 59 Luvox CR 59 Trelstar R 59 R vancomycin hydrochloride 59 BLA filing 59 authority Gurian Sherman 59 Ortho Cept 59 Icatibant 59 Camptosar ® 59 Tykerb lapatinib 59 IND Investigational New 59 equine osteoarthritis marketed 59 oxaliplatin injection 59 LymphoStat B TM 59 Celgene Thalomid 59 Nabi HB 59 Pruvel 59 Aplenzin 59 Submits Investigational 59 copromotion 59 rilonacept 59 Thalomid ® 59 Amrubicin 59 severe hypercholesterolemia 59 Evoltra ® 59 ZALBIN ™ 59 BCR ABL inhibitor 59 Zelrix 58 Cetirizine Hydrochloride Syrup 58 COLAZAL 58 sumatriptan injection 58 MK #B 58 Actemra tocilizumab 58 Augment Bone Graft 58 CIP ISOTRETINOIN 58 RAPTIVA r 58 Fortical R 58 Panzem R 58 Augment ™ 58 Lilly Cymbalta 58 supplemental biologics 58 Focalin XR R 58 SANVAR 58 ONTAK 58 Enjuvia 58 Vimpat R 58 candidate NGX 58 topical anti infective 58 PerClot 58 HepeX B TM 58 biosurgical 58 darbepoetin alfa Aranesp 58 Aldara ® 58 IND submission 58 Generic Version 58 ROTATEQ 58 containing granisetron 58 Solzira 58 Kristalose ® lactulose 58 novel trazodone formulation 58 DOV Pharmaceutical 58 Zanaflex tablets 58 CyDex Pharmaceuticals 58 TYZEKA 58 Entereg R 58 fusion enhancers 58 dorzolamide 58 Achieves Primary Endpoint 58 LEUKINE 58 Zorbtive TM 58 NASDAQ IDEV 58 Prosaptide 58 propoxyphene containing 58 OvaRex ® MAb 58 forodesine 58 Ceplene histamine dihydrochloride 58 Metformin HCl 58 Mycamine 58 SUTENT ® 58 ENTEREG ® 58 Nexavar prescribing 58 alvimopan 58 SUPPRELIN R LA 58 ALN PCS 58 sNDA filing 58 Proellex TM 58 fluvoxamine maleate 58 Pazopanib 58 Soliris eculizumab 58 Drug Applications ANDAs 58 Myocet 58 Morphine Sulfate 58 Sumatriptan Succinate 58 LUNESTA TM 58 acyclovir Lauriad R 58 DepoDur 58 Nasdaq SPNC 58 Gonal f R 58 ANDAs pending 58 XIAFLEX ™ 58 sumatriptan DosePro 58 PDX pralatrexate 58 Sutent sunitinib malate 58 Investigational Treatment 58 Somatuline Autogel 58 Filgrastim 58 MelaFind ® 58 BUPHENYL R 58 MAGE A3 ASCI 58 Gynazole 1 58 ORENCIA R 58 Visicol 58 LEVADEX ™ 58 Neurodex 58 gluteal injection 58 Alimta pemetrexed 58 Ascend Therapeutics 58 Mylotarg 58 OraTest 58 Vertex hepatitis C 58 ISO Vorin TM 58 Thelin TM 58 commercialize ZYFLO CR 58 Sycrest 58 BioDelivery Sciences 58 candidate REP# 58 StaphVAX R 58 pregabalin Lyrica 58 Fujisawa Healthcare Inc. 58 Begins Dosing 58 Anzemet 58 NasdaqGM NTEC today 58 Preotact R 58 ibuprofen Injection 58 Dementia Related Psychosis 58 subcutaneous formulation 58 Qutenza TM 58 SEASONALE R 58 Orphan Status 58 Loramyc ™ 58 XOPENEX Inhalation Solution 58 Nexavar sorafenib 58 HCl capsules 58 Meets Primary Endpoint 58 FDA Approvable Letter 58 Premarket Approval 58 Besivance 58 FDA Accepts 58 Adentri 58 NASDAQ BDSI 58 Tekturna HCT 58 Lidoderm ® 58 BioDelivery 58 BioGlue Surgical Adhesive 58 atypical antipsychotic medication 58 ANDAs pending approval 58 Zytiga 58 Aryplase 58 Renvela ® 58 RX ACCULINK 58 Gadavist 58 Ostarine TM 58 oral methylnaltrexone 58 Basilea Toctino R 58 Deferiprone 58 CAMPATH 58 CDP# 58 Gets FDA Clearance 58 Pivotal Phase III 58 Bazedoxifene 58 Retacrit 58 PrevOnco ™ 58 NASDAQ PGNX 58 Shigamabs R 58 Generic Version Of 58 NerPharMa 57 oxaliplatin Eloxatin 57 Xalatan 57 Complete Response 57 Azilect ® 57 intravenous methylnaltrexone 57 Xenazine ® 57 Taiho Pharmaceutical 57 ZEVALIN ® 57 morphine sulfate extended 57 Pfizer Sutent 57 FOR FURTHER INFORMATION ABOUT 57 Preotact ® 57 faropenem 57 Lipofen 57 Esbriet pirfenidone 57 Nasdaq AVNR 57 MNTX 57 SNT MC# 57 ORENCIA ® 57 rThrombin 57 Patient Enrollment 57 BiDil XR 57 Ticagrelor 57 Vivelle Dot ® 57 Augment Injectable 57 reslizumab 57 CRMD# 57 sitagliptin metformin 57 generic Allegra 57 elotuzumab 57 Colazal 57 Marketing Authorization Application 57 Roche OTC RHHBY 57 Receives Milestone Payment 57 Monovisc 57 CryoSeal FS System 57 Grants Orphan Drug 57 Pfizer Lyrica 57 Namenda XR 57 Surfaxin lucinactant 57 Ketotransdel 57 ALN HTT 57 XOPENEX HFA MDI 57 EHT AGN 57 Ventavis 57 HepeX B 57 Stedesa 57 LensAR Laser System 57 herpetic keratitis 57 JDS Pharmaceuticals 57 Oracea TM 57 OTC Zegerid 57 Eligard R 57 ABILIFY R 57 Oral Calcitonin 57 Nasdaq OSCI 57 proprietary intravenous formulation 57 PHX# 57 LUCASSIN 57 NEBIDO 57 PROVENGE ® 57 SPL# Gel vaginal microbicide 57 PEGINTRON TM 57 constipation OIC 57 Pegintron 57 metoprolol succinate 57 Periostat 57 KRYSTEXXA TM pegloticase 57 BLA submission 57 Generic Versions 57 Faropenem 57 IMiDs 57 FDA Approvals 57 INKP 57 Valortim TM 57 Aflibercept 57 Azathioprine 57 Daliresp 57 Indevus Pharma 57 SILENOR 57 Asentar TM 57 SURFAXIN 57 Raptiva ® 57 rhThrombin 57 RELISTOR ® 57 Marketing Authorization Application MAA 57 iloprost Inhalation Solution 57 Dyloject TM 57 EXALGO 57 UCB Cimzia 57 Omigard TM 57 MEK Inhibitor 57 Natroba 57 Cenestin 57 Testosterone Gel 57 GLASSIA 57 REBETOL combination therapy 57 ALN HPN 57 PLK1 SNALP 57 Nexavar ® 57 submit Biologics License 57 candidates Azedra TM 57 VANTAS 57 ABILIFY ® 57 AcelRx 57 Valeant Pharma 57 ZALBIN 57 QNEXA 57 methylnaltrexone 57 Tracleer ® bosentan 57 testosterone gel LibiGel 57 initiated Phase Ib 57 Tarceva TM 57 PULMICORT 57 STELARA TM 57 PRECISE Trial 57 Onsolis 57 pediatric exclusivity 57 Vfend 57 Praecis 57 Insegia 57 systemic immunosuppressive drugs 57 FORADIL 57 Fenoglide 57 Inc. NASDAQ EVVV 57 PDE# inhibitors 57 cetuximab Erbitux R 57 Allovectin 7 57 Q#IR 57 postoperative ileus POI 57 ISTODAX 57 Nipent R 57 LEP ETU 57 Zenapax 57 Serostim ® 57 Cefprozil 57 Application MAA 57 acetonide FA 57 Nasacort 57 progesterone gel 57 thetreatment 57 Xyrem ® 57 BEMA Fentanyl 57 Ondansetron Injection USP 57 Vion Pharmaceuticals 57 including eniluracil ADH 57 INTUNIV TM 57 Zenvia Phase III 57 NOXAFIL 57 Nascobal 57 naronapride 57 Relistor 57 Cancidas 57 Femring ® 57 Wafer polifeprosan 57 LUCENTIS r 57 CryoSeal 57 Begins Clinical Trial 57 Bertek Pharmaceuticals 57 TELINTRA 57 Granted Orphan Drug 57 Efficacy Results 57 Prexige lumiracoxib 57 ONGLYZA ™ 57 infusional 5-FU/LV 57 lenalidomide Revlimid R 57 XP# XP# 57 Pafuramidine 57 Hematide ™ peginesatide 57 Evoltra TM 57 REMINYL ® 57 Nebido 57 Flector pain patch 57 anti botulism antibody 57 Hedgehog Pathway Inhibitor 57 Augment ™ Bone Graft 57 antibiotic candidate Ramoplanin 56 THALOMID R 56 successfully commercialize Iluvien 56 SUSTIVA 56 Pirfenidone 56 Ranexa R 56 UPLYSO 56 markets COLAZAL 56 PANVAC VF 56 GABITRIL 56 Tamiflu oseltamivir phosphate 56 Nasdaq SLXP 56 postherpetic neuralgia PHN 56 Trobalt 56 BrachySil TM 56 Kuvan TM sapropterin 56 ELIQUIS 56 OraTest R 56 histamine dihydrochloride 56 Schizophrenia Drug 56 CAMPATH R 56 JZP 56 Nabi HB R 56 GRALISE 56 Project QTDP program 56 PF # [002] 56 Allovectin 7 r 56 Zeneus 56 Qualified Therapeutic Discovery 56 OLEPTRO TM 56 Sumavel DosePro 56 targeted radiotherapeutic 56 IDE Investigational Device Exemption 56 SILENOR TM 56 Rotarix ® 56 Diabetic Macular Edema 56 Octreotide 56 Raptiva efalizumab 56 atherothrombotic events 56 Navelbine R 56 Clindesse TM 56 Nascobal ® 56 PentaStaph 56 HP Acthar Gel repository 56 Nascobal R 56 PRISTIQ 56 Keppra ® XR 56 EMSAM 56 Taxotere docetaxel 56 Ereska 56 FENTORA 56 Angiox 56 Glycopyrrolate 56 glucocorticoid induced osteoporosis 56 Fast Track Designation 56 FIRAZYR 56 pegylated interferon alpha 56 Oxandrin R 56 SILENOR ™ 56 R rilonacept Injection 56 Zuplenz 56 ENZON 56 dasatinib Sprycel ® 56 bicifadine 56 Difimicin 56 Pentacel vaccine 56 Toctino ® alitretinoin 56 developing ACAPODENE 56 Doryx ® 56 Telavancin 56 ACTIQ 56 Alaven 56 Nasdaq PGNX today 56 Focalin XR ® 56 personalized cellular immunotherapy 56 posaconazole 56 VNS Therapy TM 56 Junovan 56 INSPIRE Trial Phase III 56 ezogabine 56 CIMZIA r 56 Phase IIb Trial 56 Kerastick 56 PROGENSA R 56 Nasdaq CYCC Nasdaq CYCCP 56 dacetuzumab collaboration 56 GTC recombinant human 56 Uvidem 56 novel oral anticoagulant 56 GEM #S 56 novel emulsion formulation 56 TRANSDUR ® 56 Glassia 56 ANDA filings 56 OSMOPREP 56 Xibrom TM 56 diazepam rectal gel 56 Increlex R 56 Product Designation 56 AzaSite Plus 56 fexofenadine hydrochloride 56 diabetic peripheral neuropathic pain 56 Clofarabine 56 Reclast Aclasta 56 aerosolized AAT 56 Mycophenolate Mofetil 56 Oncaspar 56 Biologics License Application BLA 56 intravenous formulations 56 Veronate 56 Lexiscan TM 56 FDA APPROVES 56 subsidiaries visit http:/www.apricusbio.com 56 Nektar pulmonary 56 antibacterial therapeutics 56 Tilidine 56 ZaBeCor 56 Tramiprosate ALZHEMED TM 56 VANTAS R 56 Genzyme Synvisc 56 Phase III Clinical Trial 56 diagnostic radiopharmaceutical 56 FUSILEV ® 56 Eszopiclone 56 Release Capsules 56 Gleevec imatinib mesylate 56 Genentech Rituxan 56 Receive Milestone Payment 56 M Enoxaparin 56 Esbriet ® 56 Onalta TM 56 Kosan dependence 56 include Phenoptin TM 56 Traficet EN 56 MethyPatch 56 oral taxane 56 Ozarelix 56 duloxetine hydrochloride 56 Plenaxis R 56 investigational humanized monoclonal antibody 56 Potiga 56 ThromCat 56 MKC# MKC# PP 56 Ofirmev 56 Eliquis 56 zileuton CR 56 Surgical Adhesive 56 Pacira 56 Vicuron Pharmaceuticals 56 efalizumab 56 TOPAMAX R 56 R bendamustine hydrochloride 56 TORISEL TM 56 Kuvan sapropterin dihydrochloride 56 Allovectin 7 ® 56 FACTIVE tablets 56 topical non steroidal 56 Marketing Approval PMA 56 Vascular Wrap TM 56 Vidaza R 56 Licenses Novel 56 Efudex 56 calcitonin salmon nasal spray 56 Firdapse 56 Aclasta Reclast 56 APF# 56 R bivalirudin 56 Cesamet 56 Rhucin ® recombinant 56 PROSTASCINT R 56 Spiriva Handihaler 56 drug ISA# 56 GLIADEL R 56 KNS # 56 Acurox r Tablets 56 ELADUR ™ 56 Tibotec Therapeutics division 56 PEG SN# 56 Somatuline R Depot 56 Exforge HCT 56 Zolpimist 56 successfully commercialize Silenor 56 Altoprev 56 TRELSTAR R 56 MYLOTARG 56 Extina 56 Anidulafungin 56 miconazole Lauriad R 56 Allegra Oral Suspension 56 Anika Therapeutics 56 ZEFTERA TM Zevtera TM 56 www.soliris.net 56 ILEX Oncology 56 exenatide Byetta 56 LUVOX CR 56 cethromycin NDA 56 CIP Fenofibrate 56 DepoCyt 56 ruxolitinib 56 Phase #b/#a clinical 56 Treximet 56 Zyflo 56 ridaforolimus 56 Prodarsan R 56 Rectogesic 56 Tracleer r 56 Alvesco R 56 tramiprosate ALZHEMED TM 56 opioid induced bowel dysfunction 56 Anti infective 56 AMITIZA R 56 pulls Darvon painkiller 56 Evamist TM 56 Onrigin TM 56 Gentamicin Surgical Implant 56 BioThrax R 56 OMAPRO ™ 56 Drug Applications NDAs 56 Successfully Completes Phase 56 Plenaxis 56 candidate XP# 56 Therapeutic Competitors Companies 56 corticotropin injection 56 FRDA 56 Receives Complete Response 56 Oxandrin 56 phase IIb trial 56 Oracea 56 Sprycel dasatinib 56 Glumetza TM 56 MacroChem Corporation 56 Loramyc R 56 Cladribine Tablets 56 ADVERSE EVENTS 56 SCHWARZ PHARMA 56 Ditropan XL 56 PhosLo 56 Marketing Authorization Applications 56 sapropterin dihydrochloride 56 Presents Positive 56 Aplenzin ™ 56 NAMENDA 56 oral prodrug 56 Ozurdex 56 BiovaxID TM 56 Protexia ® 56 HepaGam B 56 Adcirca 56 ACOMPLIA R 56 ZEGERID Chewable Tablets 56 Product Monograph 56 Wyeth Progenics 56 TAFA# 56 Stavzor 56 Loramyc 56 Oscient 56 refractory chronic lymphocytic 55 #D#C# 55 eprodisate Fibrillex TM 55 Acetavance 55 Zidovudine Tablets 55 PROCHIEVE 55 PMA submission 55 Angelini Labopharm 55 Patanase 55 FUSILEV 55 leading oral taxane 55 Stimuvax R 55 rALLy clinical trial 55 assigned PDUFA 55 Premarket Approval PMA 55 Ralivia TM 55 Keppra XR 55 Telatinib 55 NASDAQ INGN 55 Requip XL 55 paclitaxel Taxol R 55 Actonel ® 55 metformin accumulation 55 Aceon 55 Flutiform ™ 55 Aganocide 55 Abstral ® 55 non nucleoside inhibitor 55 IND Filing 55 motexafin gadolinium Injection 55 recombinant thrombin 55 novel histone deacetylase 55 JAK2 Inhibitor 55 DYSPORT TM 55 XIAFLEX ® 55 Major Depressive Disorder MDD 55 R sipuleucel T 55 Iluvien TM 55 amrubicin 55 Approvable letter 55 Arimidex anastrozole 55 Aflunov 55 ZADAXIN ® 55 Campto 55 Teva Provides Update 55 Prolongs Survival 55 enoxaparin sodium 55 Ketotransdel TM 55 Pivotal Phase 55 Cimzia TM 55 Injectafer 55 Metabasis stockholders 55 Silodosin 55 Prednisporin 55 Megace R ES 55 generic Prilosec 55 LibiGel ® 55 Zelapar 55 Aryx 55 Monovisc TM 55 fentanyl transdermal system 55 arsenic trioxide injection 55 treat chronic sinusitis 55 User Fee Act 55 Febuxostat 55 PNP inhibitor 55 Lilly Zyprexa 55 Daytrana ® 55 Reports Preclinical Data 55 MACUGEN 55 Sylvie Gregoire President 55 gepirone ER 55 Pliaglis 55 hydrochloride tablets